LOGIN 

 

JOIN

 

RENEW

Pulmonary Fibrosis Week

HomePatientsLung Disease Week at the ATS2019Pulmonary Fibrosis Week ▶ Information for Experts
Information for Experts

pf

 

Pulmonary Fibrosis Foundation Products

The Pulmonary Fibrosis Foundation’s (PFF) Patient Communication Center is a hub for information and resources for patients, families, and healthcare professionals. Call 844.TalkPFF (844.825.5733) or email pcc@pulmonaryfibrosis.org. We will ship our educational materials free of charge.

PFF Patient Registry
The PFF Patient Registry is a resource of data gathered from 2,000 patient volunteers across the country to help researchers further understand the disease and develop treatments.

PFF Care Center Network
The PFF’s Care Center Network is comprised of 60 medical centers nationwide offering comprehensive and individualized care to those living with PF.

PFF Research Funds
These funds support both junior and established investigator research projects.

Health Provider Educational Materials
The PFF provides digital and printed educational resources for healthcare providers including the Nursing and Allied Health Guide, the ILD Pocket Guide for physicians, and the Pulmonary Rehabilitation Pocket Guide for respiratory therapists and physical therapists. Hard copies of these materials are available for free through our Patient Communication Center.

CME/CE Library
Explore CME/CE activities relating to education about pulmonary fibrosis and ILD.

 

ATS Educational Products

DISCOVERING THE ROLE OF STEM CELL FATE IN LUNG INJURY AND FIBROSIS

FROM CANCER BIOLOGY TO NEW THERAPEUTICS: TARGETING CELL PROLIFERATION SIGNALING HUBS IN PULMONARY HYPERTENSION AND FIBROSIS

IDIOPATHIC PULMONARY FIBROSIS: CONTROVERSIES IN MANAGEMENT - PRO/CON DEBATE

ATS MYTHBUSTERS: ONE OME TO RULE THEM ALL: WE WILL FIND A COMMON PRIME MOVER FOR PULMONARY FIBROSIS

INNOVATIVE CLINICAL TRIALS IN PULMONARY FIBROSIS AND BEYOND

 


 

ClinicianATS Journals on Pulmonary Fibrosis

 

American Journal of Respiratory and Critical Care Medicine

Overlap of Genetic Risk Between Interstitial Lung Abnormalities and Idiopathic Pulmonary Fibrosis
2019
Link to Abstract

Imaging Patterns Are Associated with Interstitial Lung Abnormality Progression and Mortality
2019
Link to Abstract

The Transferrin Receptor CD71 Delineates Functionally Distinct Airway Macrophage Subsets during Idiopathic Pulmonary Fibrosis
2019
Link to Abstract

Resequencing Study Confirms That Host Defense and Cell Senescence Gene Variants Contribute to the Risk of Idiopathic Pulmonary Fibrosis
2019
Link to Abstract

Clinical Effectiveness of Antifibrotic Medications for Idiopathic Pulmonary Fibrosis
2019
Link to Abstract

Diagnostic Likelihood Thresholds that Define a Working Diagnosis of Idiopathic Pulmonary Fibrosis
2019
Link to Abstract

Role of B7H3/IL-33 Signaling in Pulmonary Fibrosis-induced Profibrogenic Alterations in Bone Marrow
2019
Link to Abstract

Poor Concordance between Sequential Transbronchial Lung Cryobiopsy and Surgical Lung Biopsy in the Diagnosis of Diffuse Interstitial Lung Diseases
2019
Link to Abstract

Lung Microbiota Contribute to Pulmonary Inflammation and Disease Progression in Pulmonary Fibrosis
2019
Link to Abstract

Impaired Cytomegalovirus Immunity in Idiopathic Pulmonary Fibrosis Lung Transplant Recipients with Short Telomeres
2018
Link to Abstract

Predicting Outcomes in Idiopathic Pulmonary Fibrosis Using Automated Computed Tomographic Analysis
2018
Link to Abstract

Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline
2018
Link to Abstract

Dicer1 Deficiency in the Idiopathic Pulmonary Fibrosis Fibroblastic Focus Promotes Fibrosis by Suppressing MicroRNA Biogenesis
2018
Link to Abstract

A Phase 2 Randomized Controlled Study of Tralokinumab in Subjects with Idiopathic Pulmonary Fibrosis
2018
Link to Abstract

 

 

American Journal of Respiratory Cell and Molecular Biology

Bleomycin Induces Drug Efflux in Lungs: A pitfall for Pharmacological Studies of Pulmonary Fibrosis
2019
Link to Abstract

Defining the Activated Fibroblast Population in Lung Fibrosis Using Single-Cell Sequencing
2019
Link to Abstract

Overexpression of TIM-3 in macrophages aggravates pathogenesis of pulmonary fibrosis in mice
2019
Link to Abstract

Intracellular Heat Shock Protein 70 Deficiency in Pulmonary Fibrosis
2019
Link to Abstract

The Antifibrotic Activity of Prostacyclin Receptor Agonism Is Mediated through Inhibition of YAP/TAZ
2019
Link to Abstract

Fibronectin on the Surface of Extracellular Vesicles Mediates Fibroblast Invasion
2019
Link to Abstract 

IL-9 Blockade Suppresses Silica-induced Lung Inflammation and Fibrosis in Mice
2019
Link to Abstract

Mitogen-activated Protein Kinase–activated Protein Kinase 2 Inhibition Attenuates Fibroblast Invasion and Severe Lung Fibrosis
2019
Link to Abstract

Involvement of Alveolar Epithelial Cell Necroptosis in Idiopathic Pulmonary Fibrosis Pathogenesis
2018
Link to Abstract

R-Spondin-2 Is Upregulated in Idiopathic Pulmonary Fibrosis and Affects Fibroblast Behavior
2018
Link to Abstract

Upregulation and Nuclear Location of MMP28 in Alveolar Epithelium of Idiopathic Pulmonary Fibrosis
2018
Link to Abstract

Lysyl Oxidase–Like 1 Protein Deficiency Protects Mice from Adenoviral Transforming Growth Factor-β1–induced Pulmonary Fibrosis
2018
Link to Abstract

 

 

Annals of ATS

Idiopathic Pulmonary Fibrosis and Lung Cancer. A Systematic Review and Meta-analysis
2019
Link to Abstract

Outcomes of Older Patients with Pulmonary Fibrosis and Non–Small Cell Lung Cancer
2019
Link to Abstract

Idiopathic Pulmonary Fibrosis Guideline Recommendations. Need for Adherence to Institute of Medicine Methodology?
2019
Link to Abstract

YouTube Videos as a Source of Misinformation on Idiopathic Pulmonary Fibrosis
2019
Link to Abstract

Increased Airway Wall Thickness in Interstitial Lung Abnormalities and Idiopathic Pulmonary Fibrosis
2019
Link to Abstract
2018 Clinical Practice Guideline Summary for Clinicians: Diagnosis of Idiopathic Pulmonary Fibrosis
2019
Link to Abstract

Procedure Preference and Intention-to-Treat Outcomes after Listing for Lung Transplantation among U.S. Adults. A Cohort Study
2019
Link to Abstract

Telomeres in Interstitial Lung Disease: The Short and the Long of It
2019
Link to Abstract

Mitochondrial Dysfunction as a Pathogenic Mediator of Chronic Obstructive Pulmonary Disease and Idiopathic Pulmonary Fibrosis
2018
Link to Abstract

Idiopathic Pulmonary Fibrosis Is a Genetic Disease Involving Mucus and the Peripheral Airways
2018
Link to Abstract

 


 

ClinicianATS Statements, Guidelines and Reports

 

An Official American Thoracic Society Workshop Report: Use of Animal Models for the Preclinical Assessment of Potential Therapies for Pulmonary Fibrosis

An American Thoracic Society Official Research Statement: Future Directions in Lung Fibrosis Research

Diagnosis of Idiopathic Pulmonary Fibrosis